Publicou 6 edições por ano
ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X
IF:
2.7
5-Year IF:
3.6
Immediacy Index:
0.8
Eigenfactor:
0.00023
JCI:
0.39
SJR:
0.42
SNIP:
0.89
CiteScore™::
5.5
H-Index:
79
Indexed in
Critical Aspects in Rationale Design of Fluorouracil-Based Adjuvant Therapies for the Management of Colon Cancer
Get access
RESUMO
The strategic goal behind adjuvant therapy is to open novel avenues for colon cancer treatment by specifically inactivating pathways needed for the growth of tumor cells. 5-Fluorouracil (5-FU) therapy is a prominent conventional treatment for colon cancer that has been used for five decades. Among the rich diversity of chemotherapeutics, 5-FU has been extensively manipulated as an anticancer drug. The pharmacology of 5-FU has spawned myriad alternatives to achieve low-toxicity treatment for better colon cancer management. The existing highly toxic chemotherapeutic regimens, lack of new congeners with significant efficacy, and drug resistance to cancer cells have prompted scientists to manipulate conventional treatments. These factors make it imperative to rationalize the current 5-FU therapy in combination with synthetic or natural compounds by optimizing the dose with respect to pharmaco-kinetic and preclinical data. To attempt to tailor effective conventional 5-FU regimens, novel therapeutic perspectives associated with the 5-FU-based colon cancer chemotherapy currently available in clinical settings have been summarized. This review presents comprehensive summary of a dedicated literature search of databases (i.e., PUBMED, CAPLUS, and MEDLINE) for adjuvant approaches such as NSAIDs (COX-II inhibitors), natural compounds, viral vectors, novel agents/molecules, and various targeted therapies, in combination with 5-FU in developing treatment alternatives for colon cancer.
-
Yang T., Peng H., Wang J., Yang J., Nice E. C., Xie K., Huang C., Prognostic and diagnostic significance of annexin A2 in colorectal cancer, Colorectal Disease, 15, 7, 2013. Crossref
-
Cools-Lartigue Jonathan, Spicer Jonathan, McDonald Braedon, Gowing Stephen, Chow Simon, Giannias Betty, Bourdeau France, Kubes Paul, Ferri Lorenzo, Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis, Journal of Clinical Investigation, 123, 8, 2013. Crossref
-
Cheng Mingrong, Liu Zheng, Wan Tao, He Bing, Zha Bingbing, Han Jiang, Chen Houxiang, Yang Fengxiao, Li Qing, Wang Wei, Xu Hongzhi, Ye Tao, Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice, Cancer Biology & Therapy, 13, 14, 2012. Crossref
-
Lee June, Kang Jong-Su, Choi Bu-Young, Keum Young-Sam, Sensitization of 5-Fluorouracil-Resistant SNUC5 Colon Cancer Cells to Apoptosis by α-Mangostin, Biomolecules & Therapeutics, 24, 6, 2016. Crossref
-
Yao Caroline, Nash Guy F, Hickish Tamas, Management of colorectal cancer and diabetes, Journal of the Royal Society of Medicine, 107, 3, 2014. Crossref
-
YANG HAIBO, YIN PEIHAO, SHI ZHAN, MA YANCHUN, ZHAO CHENGGEN, ZHENG JAMPU, CHEN TENG, Sinomenine, a COX-2 inhibitor, induces cell cycle arrest and inhibits growth of human colon carcinoma cells in vitro and in vivo, Oncology Letters, 11, 1, 2016. Crossref
-
Wu RWK, Yow CMN, Law Eric, Chu ESM, Huang Zheng, Effect of Foslip® mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells, Photodiagnosis and Photodynamic Therapy, 31, 2020. Crossref
-
Fei Bojian, Chi Alfred L, Weng Yuan, Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression, World Journal of Surgical Oncology, 11, 1, 2013. Crossref
-
Goel Honey, Razdan Karan, Singla Richu, Talegaonkar Sushama, Khurana Rajneet Kaur, Tiwary Ashok Kumar, Sinha Vivek Ranjan, Singh Kamalinder K., Engineered Site-specific Vesicular Systems for Colonic Delivery: Trends and Implications, Current Pharmaceutical Design, 26, 42, 2020. Crossref
-
Cho Namki, Ransom Tanya T., Sigmund Janet, Tran Trong, Cichewicz Robert H., Goetz Michael, Beutler John A., Growth Inhibition of Colon Cancer and Melanoma Cells by Versiol Derivatives from a Paraconiothyrium Species, Journal of Natural Products, 80, 7, 2017. Crossref
-
Sunassee Suthananda N., Ransom Tanya, Henrich Curtis J., Beutler John A., Covell David G., McMahon James B., Gustafson Kirk R., Steroidal Alkaloids from the Marine Sponge Corticium niger That Inhibit Growth of Human Colon Carcinoma Cells, Journal of Natural Products, 77, 11, 2014. Crossref
-
Cho Sung-Yun, Lee Hyo-Jeong, Cho Sun-Mi, Kim Bonglee, Jung Yeon Kwon, Kim Sung-Hoon, Particled Mica, STB-HO has chemopreventive potential via G1 arrest, and inhibition of proliferation and vascular endothelial growth factor receptor 2 in HCT colorectal cancer cells, BMC Complementary and Alternative Medicine, 13, 1, 2013. Crossref